Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2026-01-24 @ 10:14 PM
Study NCT ID:
NCT02173704
Status:
COMPLETED
Last Update Posted:
2020-08-25
First Post:
2014-06-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.
Sponsor:
GlaxoSmithKline
Organization: